Sharon Moses, MD
Obstetrics & Gynecology · Savannah, GANPI 1518966720
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $198 of the $222 with a category attached, or 89.2%. 8 manufacturers reported payments, led by AbbVie at 40.8% of the total. Reporting peaked in 2021 at $112 and has fallen 65.7% since, to $39 in 2024. That places this record below the midpoint for obstetrics & gynecology clinicians in GA, where the typical reported total is $835.
Across 12 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$91
- AMAG Pharmaceuticals, Inc.$24
- Astellas Pharma US Inc$23
- Myovant Sciences Inc.$21
- Evofem Biosciences, Inc.$16
- Scynexis, Inc.$16
- plus $31 from 2 others
What the payments were for
- Food & beverage$19889%
- Education$2411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $91 |
| AMAG Pharmaceuticals, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Myovant Sciences Inc. | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Scynexis, Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
How this compares
$222 in reported general payments places this provider in the 25th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 11 | $49 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Savannah
- Dina LinfootSavannah$12K
- Michael JacksonSavannah$9K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.